[53] Among people with ischemic heart disease on dual antiplatelet therapies, higher serum PTH levels associate with increased platelet aggregation, and a suboptimal response to clopidogrel that did not associate with the effectiveness of other antiplatelet therapies including acetylsalicylic acid or ticagrelor. Here, PTH is linked to coronary artery disorder.